All News #Library
Others
Ncardia Launches Ready-to-Use Therapeutic Screening Assays
10 Sep 2024 //
BUSINESSWIRE
Ncardia Launches Cellistic to Make Large-scale Allogeneic Cell Therapy
19 Apr 2022 //
BUSINESSWIRE
Ncardia Appoints Andy Holt as Chief Commercial Officer
24 Feb 2022 //
BUSINESSWIRE
Stem cell specialist Ncardia bags new funds to help scale manufacturing ops
18 Nov 2021 //
ENDPTS

Market Place
Sourcing Support